141 related articles for article (PubMed ID: 37706195)
1. Deficiency of salt-inducible kinase 2 (SIK2) promotes immune injury by inhibiting the maturation of lymphocytes.
Zhu J; Li C; Wang P; Liu Y; Li Z; Chen Z; Zhang Y; Wang B; Li X; Yan Z; Liang X; Zhou S; Ao X; Zhu M; Zhou P; Gu Y
MedComm (2020); 2023 Oct; 4(5):e366. PubMed ID: 37706195
[TBL] [Abstract][Full Text] [Related]
2. Salt inducible kinases 2 and 3 are required for thymic T cell development.
Nefla M; Darling NJ; van Gijsel Bonnello M; Cohen P; Arthur JSC
Sci Rep; 2021 Nov; 11(1):21550. PubMed ID: 34732767
[TBL] [Abstract][Full Text] [Related]
3. SIK2 promotes reprogramming of glucose metabolism through PI3K/AKT/HIF-1α pathway and Drp1-mediated mitochondrial fission in ovarian cancer.
Gao T; Zhang X; Zhao J; Zhou F; Wang Y; Zhao Z; Xing J; Chen B; Li J; Liu S
Cancer Lett; 2020 Jan; 469():89-101. PubMed ID: 31639424
[TBL] [Abstract][Full Text] [Related]
4. Salt-inducible kinases are required for the IL-33-dependent secretion of cytokines and chemokines in mast cells.
Darling NJ; Arthur JSC; Cohen P
J Biol Chem; 2021; 296():100428. PubMed ID: 33600797
[TBL] [Abstract][Full Text] [Related]
5. Salt-inducible kinase 2 regulates mitotic progression and transcription in prostate cancer.
Bon H; Wadhwa K; Schreiner A; Osborne M; Carroll T; Ramos-Montoya A; Ross-Adams H; Visser M; Hoffmann R; Ahmed AA; Neal DE; Mills IG
Mol Cancer Res; 2015 Apr; 13(4):620-635. PubMed ID: 25548099
[TBL] [Abstract][Full Text] [Related]
6. A potent inhibitor of SIK2, 3, 3', 7-trihydroxy-4'-methoxyflavon (4'-O-methylfisetin), promotes melanogenesis in B16F10 melanoma cells.
Kumagai A; Horike N; Satoh Y; Uebi T; Sasaki T; Itoh Y; Hirata Y; Uchio-Yamada K; Kitagawa K; Uesato S; Kawahara H; Takemori H; Nagaoka Y
PLoS One; 2011; 6(10):e26148. PubMed ID: 22022544
[TBL] [Abstract][Full Text] [Related]
7. The AMPK-related kinase SIK2 is regulated by cAMP via phosphorylation at Ser358 in adipocytes.
Henriksson E; Jones HA; Patel K; Peggie M; Morrice N; Sakamoto K; Göransson O
Biochem J; 2012 Jun; 444(3):503-14. PubMed ID: 22462548
[TBL] [Abstract][Full Text] [Related]
8. Salt-inducible kinase 2 and -3 are downregulated in adipose tissue from obese or insulin-resistant individuals: implications for insulin signalling and glucose uptake in human adipocytes.
Säll J; Pettersson AM; Björk C; Henriksson E; Wasserstrom S; Linder W; Zhou Y; Hansson O; Andersson DP; Ekelund M; Degerman E; Stenkula KG; Laurencikiene J; Göransson O
Diabetologia; 2017 Feb; 60(2):314-323. PubMed ID: 27807598
[TBL] [Abstract][Full Text] [Related]
9. Salt-inducible kinase 2 regulates TFEB and is required for autophagic flux in adipocytes.
Negoita F; Säll J; Morén B; Stenkula K; Göransson O
Biochem Biophys Res Commun; 2019 Jan; 508(3):775-779. PubMed ID: 30528240
[TBL] [Abstract][Full Text] [Related]
10. SIK2 is critical in the regulation of lipid homeostasis and adipogenesis in vivo.
Park J; Yoon YS; Han HS; Kim YH; Ogawa Y; Park KG; Lee CH; Kim ST; Koo SH
Diabetes; 2014 Nov; 63(11):3659-73. PubMed ID: 24898145
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of SIK2 and SIK3 during differentiation enhances the anti-inflammatory phenotype of macrophages.
Darling NJ; Toth R; Arthur JS; Clark K
Biochem J; 2017 Feb; 474(4):521-537. PubMed ID: 27920213
[TBL] [Abstract][Full Text] [Related]
12. Interaction between salt-inducible kinase 2 and protein phosphatase 2A regulates the activity of calcium/calmodulin-dependent protein kinase I and protein phosphatase methylesterase-1.
Lee CW; Yang FC; Chang HY; Chou H; Tan BC; Lee SC
J Biol Chem; 2014 Jul; 289(30):21108-19. PubMed ID: 24841198
[TBL] [Abstract][Full Text] [Related]
13. Reversible acetylation regulates salt-inducible kinase (SIK2) and its function in autophagy.
Yang FC; Tan BC; Chen WH; Lin YH; Huang JY; Chang HY; Sun HY; Hsu PH; Liou GG; Shen J; Chang CJ; Han CC; Tsai MD; Lee SC
J Biol Chem; 2013 Mar; 288(9):6227-37. PubMed ID: 23322770
[TBL] [Abstract][Full Text] [Related]
14. Adipose-specific expression, phosphorylation of Ser794 in insulin receptor substrate-1, and activation in diabetic animals of salt-inducible kinase-2.
Horike N; Takemori H; Katoh Y; Doi J; Min L; Asano T; Sun XJ; Yamamoto H; Kasayama S; Muraoka M; Nonaka Y; Okamoto M
J Biol Chem; 2003 May; 278(20):18440-7. PubMed ID: 12624099
[TBL] [Abstract][Full Text] [Related]
15. SIK2 is a key regulator for neuronal survival after ischemia via TORC1-CREB.
Sasaki T; Takemori H; Yagita Y; Terasaki Y; Uebi T; Horike N; Takagi H; Susumu T; Teraoka H; Kusano K; Hatano O; Oyama N; Sugiyama Y; Sakoda S; Kitagawa K
Neuron; 2011 Jan; 69(1):106-19. PubMed ID: 21220102
[TBL] [Abstract][Full Text] [Related]
16. Interaction between salt-inducible kinase 2 (SIK2) and p97/valosin-containing protein (VCP) regulates endoplasmic reticulum (ER)-associated protein degradation in mammalian cells.
Yang FC; Lin YH; Chen WH; Huang JY; Chang HY; Su SH; Wang HT; Chiang CY; Hsu PH; Tsai MD; Tan BC; Lee SC
J Biol Chem; 2013 Nov; 288(47):33861-33872. PubMed ID: 24129571
[TBL] [Abstract][Full Text] [Related]
17. Downregulation of SIK2 expression promotes the melanogenic program in mice.
Horike N; Kumagai A; Shimono Y; Onishi T; Itoh Y; Sasaki T; Kitagawa K; Hatano O; Takagi H; Susumu T; Teraoka H; Kusano K; Nagaoka Y; Kawahara H; Takemori H
Pigment Cell Melanoma Res; 2010 Dec; 23(6):809-19. PubMed ID: 20819186
[TBL] [Abstract][Full Text] [Related]
18. The Small-Molecule Inhibitor MRIA9 Reveals Novel Insights into the Cell Cycle Roles of SIK2 in Ovarian Cancer Cells.
Raab M; Rak M; Tesch R; Gasimli K; Becker S; Knapp S; Strebhardt K; Sanhaji M
Cancers (Basel); 2021 Jul; 13(15):. PubMed ID: 34359562
[TBL] [Abstract][Full Text] [Related]
19. SIK2 Improving Mitochondrial Autophagy Restriction Induced by Cerebral Ischemia-Reperfusion in Rats.
Zhang R; Liu Y; Zhong W; Hu Z; Wu C; Ma M; Zhang Y; He X; Wang L; Li S; Hong Y
Front Pharmacol; 2022; 13():683898. PubMed ID: 35586047
[TBL] [Abstract][Full Text] [Related]
20. Salt-Inducible Kinase 2: An Oncogenic Signal Transmitter and Potential Target for Cancer Therapy.
Chen F; Chen L; Qin Q; Sun X
Front Oncol; 2019; 9():18. PubMed ID: 30723708
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
